Myelinating Glia: Potential Therapeutic Targets in Polyglutamine Spinocerebellar Ataxias
Human studies, in combination with animal and cellular models, support glial cells as both major contributors to neurodegenerative diseases and promising therapeutic targets. Among glial cells, oligodendrocytes and Schwann cells are the myelinating glial cells of the central and peripheral nervous s...
Main Authors: | Alexandra F. Putka, Juan P. Mato, Hayley S. McLoughlin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/12/4/601 |
Similar Items
-
Pathogenetic Mechanisms Underlying Spinocerebellar Ataxia Type 3 Are Altered in Primary Oligodendrocyte Culture
by: Kristen H. Schuster, et al.
Published: (2022-08-01) -
Motor Exit Point (MEP) Glia: Novel Myelinating Glia That Bridge CNS and PNS Myelin
by: Laura Fontenas, et al.
Published: (2018-10-01) -
SARM1 detection in myelinating glia: sarm1/Sarm1 is dispensable for PNS and CNS myelination in zebrafish and mice
by: Shaline V. Fazal, et al.
Published: (2023-04-01) -
White matter changes in Alzheimer’s disease: a focus on myelin and oligodendrocytes
by: Sara E. Nasrabady, et al.
Published: (2018-03-01) -
Lactate Transporters Mediate Glia-Neuron Metabolic Crosstalk in Homeostasis and Disease
by: Mithilesh Kumar Jha, et al.
Published: (2020-09-01)